​

Autolus Therapeutics Ownership | Who Owns Autolus Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Autolus Therapeutics Ownership Summary

Autolus Therapeutics is owned by 62.34% institutional investors, 18.09% insiders, and 19.58% retail investors. Wellington management group llp is the largest institutional shareholder, holding 9.53% of AUTL shares. Syncona Ord is the top mutual fund, with 11.55% of its assets in Autolus Therapeutics shares.

AUTL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAutolus Therapeutics62.34%18.09%19.58%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Wellington management group llp25.35M9.53%$59.56M
Blackstone20.49M7.70%$46.71M
Mak capital one16.96M6.37%$38.66M
Deep track capital, lp16.85M6.33%$38.42M
Syncona portfolio16.64M6.25%$37.94M
Fmr15.63M5.87%$36.74M
Armistice capital12.00M4.51%$27.36M
Tfg asset management gp8.25M3.10%$19.39M
Blackrock4.44M2.00%$15.44M
Frazier life sciences management4.62M1.74%$10.54M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Syncona portfolio16.64M98.24%$37.94M
Mak capital one16.96M5.54%$38.66M
Tfg asset management gp8.25M4.78%$19.39M
Deep track capital, lp16.85M1.23%$38.42M
Healthinvest partners ab1.11M1.08%$2.52M
Affinity asset advisors3.04M0.95%$6.94M
Armistice capital12.00M0.47%$27.36M
Frazier life sciences management4.62M0.42%$10.54M
Aubrey capital management452.20K0.38%$1.05M
Diametric capital, lp279.69K0.34%$637.69K

Top Buyers

HolderShares% AssetsChange
Mak capital one16.96M5.54%16.96M
Morgan stanley2.90M0.00%2.21M
Axa1.82M0.01%1.82M
Wellington management group llp25.35M0.01%1.13M
Armistice capital12.00M0.47%1.00M

Top Sellers

HolderShares% AssetsChange
Avoro capital advisors---9.91M
Cormorant asset management, lp---6.62M
Paradigm biocapital advisors lp---6.43M
Perceptive advisors---4.33M
Deerfield management company, l.p. (series c)---3.64M

New Positions

HolderShares% AssetsChangeValue
Mak capital one16.96M5.54%16.96M$38.66M
Axa1.82M0.01%1.82M$4.29M
Ubs oconnor565.00K0.07%565.00K$1.29M
Diametric capital, lp279.69K0.34%279.69K$637.69K
Xtx topco168.25K0.02%168.25K$383.62K

Sold Out

HolderChange
Us bancorp \de\-64.00
Cornerstone planning group-100.00
Cubist systematic strategies-160.00
Carmichael hill & associates-254.00
Skopos labs-377.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202593-2.11%165,894,0399.60%621.93%4925.64%27-15.63%
Mar 31, 202595-12.04%168,007,060-0.18%631.58%39-29.09%326.67%
Dec 31, 20241053.96%163,675,281-8.36%611.37%5450.00%30-16.67%
Sep 30, 202499-10.00%178,343,7070.33%671.05%36-33.33%3520.69%
Jun 30, 2024110-9.09%177,754,5781.37%801.28%54-23.94%297.41%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Syncona Ord30.73M11.55%9.39M
Vanguard Health Care Inv19.36M7.27%-
FIAM Small Cap Core CIT Cl B4.02M1.51%946.70K
FIAM Small Cap Core Composite3.14M1.18%-26.57K
Fidelity Small Cap Growth2.57M0.97%-
International Biotechnology Ord2.41M0.90%472.01K
AXA Framlington Health Fund - R Income2.37M0.89%-751.84K
US Small-Cap Growth II Equity Comp2.02M0.76%-216.32K
T. Rowe Price New Horizons2.02M0.76%-10.05K
Wellington Global Hlthcr Eq USD G Ac1.79M0.67%-

AUTL Ownership FAQ

Who Owns Autolus Therapeutics?

Autolus Therapeutics shareholders are primarily institutional investors at 62.34%, followed by 18.09% insiders and 19.57% retail investors. The average institutional ownership in Autolus Therapeutics's industry, Biotech Stocks , is 306.59%, which Autolus Therapeutics falls below.

Who owns the most shares of Autolus Therapeutics?

Autolus Therapeutics’s largest shareholders are Wellington management group llp (25.35M shares, 9.53%), Blackstone (20.49M shares, 7.70%), and Mak capital one (16.96M shares, 6.37%). Together, they hold 23.59% of Autolus Therapeutics’s total shares outstanding.

Does Blackrock own Autolus Therapeutics?

Yes, BlackRock owns 2.00% of Autolus Therapeutics, totaling 4.44M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 15.44M$. In the last quarter, BlackRock increased its holdings by 380.18K shares, a 9.37% change.

Who is Autolus Therapeutics’s biggest shareholder by percentage of total assets invested?

Syncona portfolio is Autolus Therapeutics’s biggest shareholder by percentage of total assets invested, with 98.24% of its assets in 16.64M Autolus Therapeutics shares, valued at 37.94M$.

Who is the top mutual fund holder of Autolus Therapeutics shares?

Syncona Ord is the top mutual fund holder of Autolus Therapeutics shares, with 11.55% of its total shares outstanding invested in 30.73M Autolus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools